Early Immune System Development and Ontogeny (R01 Clinical Trial Optional)
Early Immune System Development and Ontogeny (R01 Clinical Trial Optional) is a published development and funding opportunity on Contexium. The donor or funder is National Institutes of Health. Project location(s): United States. Applications close on 05 Nov 2028. Budget: 400,000 USD. The purpose of this Notice of Funding Opportunity (NOFO) is tofurther elucidate the mechanisms of early immune development in utero, during the early post-natal period and during early childhood in neonates, infants, and children and adolescents with or without in-utero exposure to HIV or Anti-Retro…
Opportunity overview
- Project name
- Early Immune System Development and Ontogeny (R01 Clinical Trial Optional)
- Donor
- National Institutes of Health
Key details
- Opportunity start date
- Opportunity end date
- Project location(s)
- United States
- Budget
- 400,000
- Currency
- US Dollar
Summary
Frequently asked questions
What is Early Immune System Development and Ontogeny (R01 Clinical Trial Optional)?
Early Immune System Development and Ontogeny (R01 Clinical Trial Optional) is a published development and funding opportunity on Contexium. The donor or funder is National Institutes of Health. Project location(s): United States. Applications close on 05 Nov 2028. Budget: 400,000 USD. The purpose of this Notice of Funding Opportunity (NOFO) is tofurther elucidate the mechanisms of early immune development in utero, during the early post-natal period and during early childhood in neonates, infants, and children and adolescents with or without in-utero exposure to HIV or Anti-Retro…
Who is funding Early Immune System Development and Ontogeny (R01 Clinical Trial Optional)?
Early Immune System Development and Ontogeny (R01 Clinical Trial Optional) is funded by National Institutes of Health.
When is the deadline to apply for Early Immune System Development and Ontogeny (R01 Clinical Trial Optional)?
The application deadline is 05 Nov 2028 00:00 (UTC).
Where will the Early Immune System Development and Ontogeny (R01 Clinical Trial Optional) project take place?
The project location(s) are: United States.
What is the budget for Early Immune System Development and Ontogeny (R01 Clinical Trial Optional)?
The available budget is 400,000 USD.
How can I apply for Early Immune System Development and Ontogeny (R01 Clinical Trial Optional)?
Create a free Contexium account to view the full opportunity details and submit an application via the marketplace.